Society Lab is an EdTech company with international ambitions. We create the "digital gym" that gets leaders in shape to master tomorrow and fast-track an inclusive and sustainable economy. We use technology to tailor learning to the individual leader and we offer to learn as a subscription. Through this, we will help companies close the competence gap so that they become relevant also tomorrow. We have successfully passed the first phase of being a start-up, have customers, are financially solid, have come a long way in verifying our concept in the market, and will now rig to build the technology to scale the company.

SonoClear AS develops an acoustic contrast fluid to remove noise in ultrasound images, used during brain tumor surgery to guide tumor removal. The goal is to be sure that all tumor is removed, as total resection improves patient outcomes. The technology is developed by neurosurgeons at St.Olavs hospital and engineers at Sintef. The technology is patented worldwide and is developed as a medical device according to ISO13485. The core team consists of CTO, Medical advisor, Quality manager, and Regulatory officer. SonoClear plan for market access in USA and EU in 4q20 and 4q21, respectively.

Med-Storm's Skin Conductance Algesimeter (SCA) uses the principle of skin conductance to measure pain, allowing us to titrate the right amount of pain medication for each, individual patient. This award-winning technology is not affected by changes in blood circulation, heart rate, hypotensia, environmental temperatures, and hypoxia, and shows low variation between individuals at the same level of pain. The pain monitor can be used on patients as young as 23 weeks of gestational age, as well as geriatric patients. MS is currently working on a miniaturized and wireless version of the SCA.

You are not a product. Why let your inbox be sold to advertisers? Fjordmail is your private, secure, and green email service. Fjordmail aims to offer the following:-- Secure and privacy-aware email service with a modern and easy-to-use interface-- Take full control of your inbox and say goodbye to spam through pre-qualification of senders-- One-click access to add additional encryption for sensitive emails-- Protection by strict Norwegian privacy law in addition to EU legislation. Our first customers have already joined Fjordmail with our "minimal viable product" which is already in the market. Our addressable segment of the email market is growing by 40-60% p.a.Click here to find out more about Fjordmail

Disruptive Engineering enables more effective planning, management, and monitoring of road networks. Proprietary sensor hardware 'made in Norway'Use AI and neural networks for detailed classification of vehicles. Privacy-by-design solution ensuring that no personal data is stored or shared. With traffic expected to grow by 60% by 2050, and with congestion and safety already being an issue, there is a pressing need to utilize road networks more efficiently. Both Statens Vegvesen and Nye Veier see our first sensor VS1, and the valuable data it provides, as a potential solution to achieve this as well as an opportunity to digitalize roads and infrastructure for the forthcoming Intelligent Transportation Systems (ITS) that are being implemented across Europe.Statens Vegvesen linkNye Veier link

Manolin is a software company focusing on digital health management to accelerate resource sharing between salmon farms. We are a software and data analytics company helping global aquaculture scale sustainably. 🌊 Our ocean faces many challenges, but it holds even more potential for positive impact. Our goal is to help build a more sustainable future food system together with aquaculture farmers.

AutoGlove is the first product from Ecocentric Innovation. A product development company with a sustainability focus. We are a forward-thinking team with several years of technological experience, and new innovations in the pipeline. The Idea for AutoGlove originated when one of our founders; Monty Hatfield visited a gas station and witnessed the unhygienic, extensive, and ineffective use of disposable gloves. During his studies at the Norwegian University of Life Sciences, he recruited a team to develop the product AutoGlove. Thus, Ecocentric Innovation was born and we now work with companies across many sectors to reduce unnecessary disposable glove waste.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

BRIK as is a company specialising in new web technology, pedagogy and professional dissemination of knowledge. The team has extensive experience in the dissemination of knowledge with new web technologies and video. Our investors and partners are Innovation Norway, the Norwegian Research Council and several customer partners. The budget for the initial development phase (2013 - ) has been 12 MNOK. Now we are looking for partners for the next stage, where we will commercialize and increase sales.

Our vision is to help industry and nature to coexist. 🦅 With the current pressure on nature, biodiversity management is bound to see a new wave of regulations and increased pressure on industry to monitor, measure and reduce its impact. We help industry tackle this challenge with our proprietary biodiversity monitoring technology.

Skyfri Technologies AS is a global and fast-growing clean technology company based in Oslo, Calgary, Singapore and Hyderabad. Our advanced proprietary technology, powered by machine learning and big data, will completely digitize the way asset owners operate their power plants, and help them improve uptime and production. Our vision is to accelerate the deployment of renewable energy globally and we believe that software will be the engine to achieve that goal.

Live healthier, easy: Our digitalized nutritionist shows the way, far away from calorie counting and extreme diets. As a company, we're working towards a healthier society on global scale – and global impact, starts internally; We believe a healthy job experience sets you up to thrive professionally and personally. You find our growing and remote team distributed through Europe, where it’s not about showing up at one office every day, but showing up at your best. Do yourself and the world a favor; look through our website and send us a message to carl@anti.diet, and let's see what we can do together!

Bad Forecasts Kill Businesses: Working capital cost, natural resource waste, overproduction, lost sales... MIR is the Sherlock Holmes for your business. We identify the most important influence factors out of billions of market data for maximum profit, minimum waste, thanks to the best forecasting accuracy.

Cloud Insurance is a seamless and user-friendly SaaS solution made by insurance experts for insurance companies, MGAs, agents, and brokers since 2016. Founded by ambitious minds. While studying together, our founders observed various complications in the insurance industry. Being two ambitious and tech-savvy students, they decided to help and challenged the status quo. After many sleepless nights, they launched the first version of a SaaS product to serve our first client. Partner – not a vendor. Our international team consists of techies, ex-consultants, and heavy hitters from the finance and insurance industries. We know everything about your daily operations, and we're determined to make them more productive and cost-efficient. We aren't a vendor but a partner who works to help you act faster and innovate easier. And we have lots of templates in place so that the process will take weeks, not years or months. Customer-first company. We're finalists of many insurtech competitions, but this is not as important as the great feedback we get from our clients. Thanks to our platform, on average, we see up to a 50% decrease in time-to-market and a 40% increase in revenue. While many of our competitors are just announcing innovative features, our clients have been using them for a while.

DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug development more effective. We use state-of-the-art methods to improve patients’ quality of life and help clinicians make more informed decisions. Our technology is based on pioneering research on utilizing artificial intelligence to increase the prognostic value from routine clinical pathology cancer tissue samples. The extensive research conducted at top universities (University in Oslo, Oxford University and University College of London) has been published in leading and high impact scientific journals such as The Lancet and Nature Reviews Cancer. These new methods have resulted in fully automated histotyping that provide objective and precise prognostic information that correlate and out-perform existing markers. This novel histotyping can guide selection of therapy to avoid over- and undertreatment. It can also make cancer drug development more effective by ensuring more precise diagnosis and prognosis, which is the fundament for precision medicine. Artificial intelligence is set for a breakthrough in medicine and several megatrends are pushing for new solutions in cancer diagnostics. Digital pathology and new AI algorithms will play a significant role in the future of medicine and hold multiple commercial opportunities. DoMore Diagnostics is at the forefront of the field and will bring these next generation products to the clinic.